Document:

EXHIBIT 10.10  

[LETTERHEAD OF IMAGES
TECHNOLOGIES INC.] 

October 8, 2002 

Intacta Technologies, Inc.

Resurgens Plaza South

945 E. Paces Ferry Road, N.E. 

Suite 1445

Atlanta, Georgia

30326 

Dear Sirs/Mesdames: 

Intacta Technologies, Inc.
(“Intacta”) has developed certain data encoding technologies which may be used
in combination with technologies developed by Imagis Technologies Inc.
(“Imagis”). Under an agreement dated August 30, 2002 (the “Original
Agreement”), Imagis acquired rights to the Intacta Technology for use in specified
fields. In this Agreement, “Intacta Technology” has the same meaning as set out
in the Original Agreement. 

Under the Original Agreement, Intacta
was to retain sufficient employees to provide technical support to Imagis and purchasers
of the Intacta Technology, and to further develop the Intacta Technology. In support of
its obligations under the Original Agreement, Intacta also agreed to escrow the source
code for the Intacta Technology. 

Intacta and Imagis have agreed that
the obligations of Intacta to maintain and develop the Intacta Technology for the
customers of Imagis are better carried out by Imagis. Accordingly, Intacta and Imagis have
agreed to amend the Original Agreement. 

1.     Amendment of Original
Agreement 

Paragraphs 3 (Source Code Escrow) and
4 (Intacta Employees) of the Original Agreement are deleted and replaced by the following: 

	  	
“3.   Source Code  

	  	
Intacta
will provide to Imagis, as soon as practicable, a copy of the source code, software
listings, functional specification and other written and/or magnetic material and all
related documentation necessary (together, the “Data”) to enable an independent,
reasonably-skilled programmer to understand, maintain, modify, correct and enhance the
Intacta Technology. 

	  	
Intacta
will ensure that while the License is outstanding, the Data will be kept fully up-to-date
and will accurately reflect all modifications, amendments, updates, new releases and
levels relating to the Intacta Technology (“Updates”), 

-2- 

	  	
and
for such purposes, Intact will provide to Imagis a copy of any Update within three days
of its availability.  

	  	
Imagis
may use the Data to provide maintenance services, or software updates or upgrades, to
purchasers of the Intacta Technology. Nothing herein will restrict Imagis from offering
employment to any persons employed by Intacta, nor will Imagis be required to hire any
Intacta personnel.” 

2.     One Agreement 

This Amending Agreement is
supplemental to the Original Agreement and will form one instrument with the Original
Agreement. The Original Agreement will be treated as being amended only to the extent
provided in this Amending Agreement and all the provisions of the Original Agreement, as
amended, are hereby confirmed and will continue in full force and effect.  

3.     Further Assurances 

Each of Imagis and Intacta will, at
its own expense and without expense to the other, execute and deliver such further
agreements and other documents and do such further acts and things as the other party
reasonably requests to evidence, carry out or give full force and effect to the intent of
this Amending Agreement. 

4.     Fees and Expenses 

Each of Imagis and Intacta agrees
that it will pay its own fees and expenses, and the fees and expenses of its
representatives, including any fee for advice or opinions incurred in connection with the
negotiation, preparation, execution and delivery of this Amending Agreement and any other
agreements contemplated thereby. Each of Imagis and Intacta represents and warrants that
it has not incurred any liability for any finder’s fee or broker’s commission in
connection with the execution of this Amending Agreement. 

5.     Publicity 

Neither Imagis nor Intacta will make
any press release, public announcement or public statement about the transactions
contemplated herein which has not been previously approved by the other party, except that
either party may make a press release or filing with a regulatory authority if counsel for
such party advises that such press release or filing is necessary (in which case such
party will first make a reasonable effort to obtain the approval of the other). 

6.     Assignment 

Neither party may assign this
Amending Agreement without the written consent of the other party, except that Imagis may
assign this Amending Agreement at any time to an affiliate. 

-3- 

7.     Entire Agreement 

This Amending Agreement and the
Original Agreement (together, the “Agreements”) constitute the entire agreement
between Imagis and Intacta and supersedes every previous agreement, communication,
expectation, negotiation, representation or understanding, whether oral or written,
express or implied, statutory or otherwise, between the parties with respect to the
subject matter of the Agreements. No director, officer, employee or agent of either Imagis
or Intacta has any authority to make any representation or commitment not contained in
this Amending Agreement, and each party has executed this Amending Agreement without
reliance upon any such representation or commitment. 

8.     Governing Law 

This Amending Agreement is and will
be deemed to be made in British Columbia, for all purposes will be governed exclusively by
and construed and enforced in accordance with the domestic laws prevailing in British
Columbia, other than the International Sale of Goods Act (British Columbia), and
the rights and remedies of Imagis and Intacta will be determined in accordance with such
domestic laws. 

9.     Attornment 

Each of Imagis and Intacta
irrevocably and exclusively attorns to the jurisdiction of the courts of British Columbia
and all courts having appellate jurisdiction thereover, and any proceeding commenced or
maintained by Imagis or Intacta in respect of or arising because of this Amending
Agreement will be commenced or maintained only in such of those courts as is appropriate. 

10.    Counterparts 

This Amending Agreement may be
executed in any number of counterparts with the same effect as if Imagis and Intacta had
signed the same document, and all counterparts will be construed together and constitute
one and the same instrument. 

Yours very truly, 

IMAGIS TECHNOLOGIES INC. 

Per:  signed “Iain Drummond”
              

        Authorized Signatory

Acknowledged, accepted and agreed to
October 8th, 2002. 

INTACTA TECHNOLOGIES,
INC. 

Per:  signed “Noel Bambrough”
          

        Authorized SignatoryEXHIBIT 10.12  

[LETTERHEAD OF IMAGIS
TECHNOLOGIES INC.] 

November 1, 2002 

	
Intacta Technologies, Inc.

Resurgens Plaza South

945 E. Paces Ferry Road, N.E.

Suite 1445

Atlanta, Georgia

30326
 	
Intacta Labs Ltd. and

Gad Naaman

c/o Intacta Technologies, Inc.

Attention:  Noel Bambrough  

Dear Sirs/Mesdames: 

Intacta Technologies, Inc.
(“Intacta”) has developed or owns the rights to certain data compression
technologies which have been patented in various jurisdictions. Imagis Technologies Inc.
(“Imagis”) wishes to acquire the patents owned by Intacta (the “Intacta
Patents”) listed in the attached Exhibit A. Imagis also wishes to acquire an
exclusive license from Intacta Labs Ltd. (“Labs”), former Fontech Ltd., a
wholly-owned subsidiary of Intacta, certain patents (the “Labs Patents”) listed
in the attached Exhibit B. Certain of the Intacta Patents are registered in the name of
Labs. Gad Naaman (“Naaman”), an employee of Labs, is the holder of certain of
the Labs Patents which he has assigned to Labs. 

1.     Acquisition  

In consideration for US$50,000 (the
“Purchase Price”), 

	(a)  	  	Intacta
and Labs hereby grant, sell, assign, transfer and convey to Imagis, its
          successors and assigns, the entire right, title and interest in and to  

	  	(i)	the
Intacta Patents and all rights in respect thereof,  

		(ii)	all
income, royalties, damages and payments now and hereafter due or payable           under
and with respect to the Intacta Patents, and  

		(iii)	the
right to sue for past, present and future infringements of the Intacta           Patents;
and  

	(b)  	  	Labs
hereby grants to Imagis a fully paid-up license to use the Labs Patents           (the
“License”) with a further right to acquire the Labs Patents at           any
time for nominal consideration.  

The License is exclusive to Imagis
(even to the exclusion of Intacta), royalty-free and has a term that expires on the latest
expiry date of a Labs Patent. 

-2- 

The Purchase Price will be payable as
to US$33,000 (the “Initial Payment”) on the execution of this Agreement, with
the balance of the Purchase Price will be payable on the verification of the Data (as
defined in paragraph 2) and the delivery to Imagis of any documents Imagis requires in
order to transfer the Intacta Patents. Imagis and Intacta confirm that US$33,000 has been
advanced by Imagis to Intacta and that this amount will be credited towards the Initial
Payment. Notwithstanding these payment terms, the sale of the Intacta Patents will be
effective from the date the Initial Payment is made. 

2.     Source Code  

Intacta will provide to Imagis, as
soon as practicable after the execution of this Agreement, a copy of the source code,
software listings, functional specifications and all other written and/or magnetic
material and related documentation necessary (together, the “Data”) to practice
the Intacta Patents. Intacta will be required to provide any updates of the Data to
Imagis. Imagis will have no limitations on its use of the Data. 

3.     Intacta Employees  

Nothing herein will restrict Imagis
from offering employment to any persons employed by Intacta or Labs, nor will Imagis be
required to hire any Intacta or Labs personnel. 

4.     Representations, Warranties and Indemnity  

Intacta and Labs jointly and
severally represent and warrant to Imagis that the Intacta Patents and Labs Patents are
free and clear of all encumbrances, and that the Intacta Patents and Labs Patents
represent all patents and patent applications of Intacta, Labs and their affiliates,
except for certain U.S. patents of Intacta. 

Intacta, Labs and Imagis each
represent to the other that all necessary consents have been obtained to enter into this
Agreement and complete the sale of the Intacta Patents and the licensing of the Labs
Patents to Imagis. Intacta also represents that the transactions contemplated under this
Agreement will not constitute a disposition of all or substantially all of the assets of
Intacta. 

Intacta and Labs will indemnify,
defend (or at Intacta’s option and expense but only with the consent of Imagis)
settle, and hold Imagis and each of its affiliates and their officers, directors,
employees, agents, distributors and licensees (the “Imagis Indemnified Parties”)
harmless from and against any judgement, claim, action, proceeding, losses, deficiencies,
damages, liabilities, costs and expenses (including reasonable attorneys’ fees and
expenses), that may be incurred by an Imagis Indemnified Party in any connection with any
claim, demand, suit, action or proceeding arising as a result of an allegation that any of
the Intacta Patents or Labs Patents infringe on the intellectual property rights of
another party. 

5.     Right to Acquire Labs  

Intacta grants to Imagis the right to
acquire all outstanding shares of Labs held (directly or indirectly) by Intacta (the
“Intacta Labs Shares”) in consideration for an amount equal to the fair market
value of such shares (the “Labs Option”). If Labs has no business or assets  

-3- 

other than the Labs Patents, the fair
market value of the Intacta Labs Shares will be deemed to be $1.00. The Labs Option will
expire on the latest expiry date of the Labs Patents.  

6.     Further Assurances  

Imagis, Intacta and Labs will, at
their own expense and without expense to the other, execute and deliver such further
agreements and other documents and do such further acts and things as the other party
reasonably requests to evidence, carry out or give full force and effect to the intent of
this Agreement, including all documents required, if applicable, to transfer the Intacta
Patents, Labs Patents and the Lab Shares to Imagis. Intacta hereby irrevocably grants to
Imagis a power of attorney to transfer the Intacta Patents and the Lab Shares. 

7.     Fees and Expenses  

Imagis, Intacta and Labs each
represents and warrants that it has not incurred any liability for any finder’s fee
or broker’s commission in connection with the execution of this Agreement. Imagis,
Intacta and Labs each agree they will pay their own and their representatives fees and
expenses, including any fee for advice or opinions incurred in connection with the
negotiation, preparation, execution and delivery of Agreement and any other agreements
contemplated thereby. 

8.     Publicity  

None of Imagis, Intacta or Labs will
make any press release, public announcement or public statement about the transactions
contemplated herein which has not been previously approved by the other, except that
either party may make a press release or filing with a regulatory authority if counsel for
such party advises that such press release or filing is necessary (in which case such
party will first make a reasonable effort to obtain the approval of the other). 

9.     Assignment  

This Agreement may not be assigned by
Intacta or Labs without the written consent of Imagis. Imagis may assign this Agreement at
any time to any party without prior notice to, or the need to obtain the consent of,
Intacta or Labs. 

10.    Acknowledgement by Naaman  

Naaman acknowledges the agreements
and covenants of Labs in this Agreement and, if required, consents to the grant of the
License by Labs. 

11.  Entire Agreement  

This Agreement constitutes the entire
agreement between the parties and supersedes every previous agreement, communication,
expectation, negotiation, representation or understanding, whether oral or written,
express or implied, statutory or otherwise, between the parties with respect to the
subject matter of this Agreement. No director, officer, employee or agent of any 

-4- 

party has any authority to make any
representation or commitment not contained in this Agreement, and each party has executed
this Agreement without reliance upon any such representation or commitment. 

12.    Governing Law  

This Agreement is and will be deemed
to be made in British Columbia, Canada, for all purposes will be governed exclusively by
and construed and enforced in accordance with the domestic laws prevailing in British
Columbia, Canada, and the rights and remedies of Imagis and Intacta will be determined in
accordance with those domestic laws. 

13.    Attornment  

Imagis, Intacta and Labs irrevocably
and exclusively attorns to the jurisdiction of the courts of British Columbia, Canada and
all courts having appellate jurisdiction thereover, and any proceeding commenced or
maintained by a party in respect of or arising because of this Agreement will be commenced
or maintained only in such of those courts as is appropriate. 

14.    Counterparts  

This Agreement may be executed in any
number of counterparts with the same effect as if Imagis, Intacta and Labs had signed the
same document, and all counterparts will be construed together and constitute one and the
same instrument. 

Yours very truly, 

IMAGIS TECHNOLOGIES INC. 

Per:  signed “Wayne Smith”
                  

        Authorized Signatory

Acknowledged, accepted and agreed to
November 4th, 2002. 

INTACTA TECHNOLOGIES,
INC. 

Per:  signed “Ross Wilmot”
          

        Authorized Signatory  

-5- 

INTACTA LABS LIMITED 

Per:  signed “Naaman Gad”
          

        Authorized Signatory  

	Signed, Sealed and Delivered
by Gad Naaman	 	)	 	 	 
	in the presence of:	 	)	 	 	 
	 	 	)	 	 	 
	 	 	)	 	 	 
	signed "Ilia Saveliev"	 	)	 	Signed "Gad Naaman"	 
	
	 	)	 	
	 
	Witness (Signature)	 	)	 	Gad Naaman 	 
	 	 	)	 		 
	ILIA SAVELIEV	 	)	 	 	 
	
	 	)	 	 	 
	Name (please print)	 	)	 	 	 
	 	 	)	 	 	 
	KLATCHKIN 17L3	 	)	 	 	 
	
	 	)	 	 	 
	Address	 	)	 		 
	 	 	)	 	 	 
	BEERSHEVA, ISRAEL	 	)	 	 	 
	
	 	)	 	 	 
	City, Country	 	)	 	 	 

Exhibit A

List of Intacta Patents  

	Jurisdiction or

Country	
Patent No. or

Application No.	
Date Granted or

Date Filed	
Description of Patents
	

	Canada	 	Application No. 2,046,835	 	Filed July 11, 1991	 	Graphic matter and process and
apparatus for producing, transmitting and reading the same	 
	

	South Africa	 	Patent No. 91/5410	 	August 26, 1992	 	Graphic matter and process and apparatus	 
		 		 		 	for producing, transmitting and reading the	 
		 		 		 	same	 
	

	Australia	 	Patent No. 642508	 	Granted March 7, 1994	 	Graphic matter and process
and apparatus for producing, transmitting and reading the same	 
	

	Europe	 	Patent No. 0466146	 	Granted January 14, 1998 	 	Graphic matter and process
and apparatus
for producing, transmitting and reading the same	 
	

	United Kingdom	 	Patent No. 0466146	 	Granted January 14, 1998 	 	Graphic matter and process
and apparatus for producing, transmitting and reading the same	 
	

	Canada	 	Application No.	 	Filed April 20, 1999	 	Process and apparatus for transmitting,
receiving and/or storing information	 
	

	Europe	 	Application No. 

99914740.8	 	Filed April 20, 1999	 	
Process and apparatus for transmitting, receiving and/or storing information	 
	

	France	 	Application No. 

99914740.8	 	Filed April 20, 1999	 	Process and apparatus for transmitting,
receiving and/or storing information	 
	

	Germany	 	Application No. 

99914740.8	 	Filed April 20, 1999	 	Process and apparatus for
transmitting, receiving and/or storing information	 
	

	International Procedure	 	Application No. 

PCT/IL99/00208	 	Filed April 20, 1999	 	Process and apparatus for transmitting,
receiving and/or storing information	 
	

	Japan	 	Application No. 

2000-545279	 	Filed April 20, 1999	 	Process and apparatus for transmitting,
receiving and/or storing information	 
	

	United Kingdom	 	Application No. 

99914740.8	 	Filed April 20, 1999	 	Process and apparatus for transmitting,
receiving and/or storing information
	 
		 		 		 		 
	

	Canada	 	Application No. 

2,102,952	 	Filed November 12, 1993	 	Process and apparatus for transmitting
and/or storing information	 
	

	Jurisdiction or

Country	
Patent No. or

Application No.	
Date Granted or

Date Filed	
Description of Patents
	

	Japan	 	Application No.

5-285375	 	Filed November 15, 1993	 	
Process for transmitting and/or storing information	 
	

	Germany	 	Patent No. 0598357	 	Granted February 24,	 	Process and apparatus for transmitting	 
		 		 	1999	 	and/or storing information	 
	

	France	 	Patent No. 0598357	 	Granted February 24,	 	Process and apparatus for transmitting	 
		 		 	1999	 	and/or storing information	 
	

	United Kingdom	 	Patent No. 0598357	 	Granted February 24,	 	Process and apparatus for transmitting	 
		 		 	1999	 	and/or storing information	 
	

	Europe	 	Patent No. 0598357	 	Granted February 24,	 	Process and apparatus for transmitting	 
		 		 	1999	 	and/or storing information	 
	

Exhibit B

List of Labs Patents  

	
Jurisdiction

or Country	
Patent No. or

Application No.	
Date Granted or

Date Filed	
Description of Patents
	

	Israel	 	Patent No. 96118	 	Granted December 31, 1995	 	Graphic matter and process and apparatus	 
		 		 		 	for producing, transmitting and reading the same	 
	

	Israel	 	Patent No. 96969	 	Granted January 10, 1997	 	Graphic matter and process and apparatus	 
		 		 		 	for producing, transmitting and reading the	 
		 		 		 	same	 
	

	Israel	 	Patent No. 96973	 	July 13, 1997	 	Graphic matter and process and apparatus	 
		 		 		 	for producing, transmitting and reading the	 
		 		 		 	same	 
	

	Israel	 	Patent No. 103755	 	February 16, 1997	 	Process for transmitting and/or storing	 
		 		 		 	information	 
	

	Israel	 	Patent No. 105493	 	Granted August 16, 1999	 	Process for transmitting and/or storing	 
		 		 		 	information	 
	

	Israel	 	Application No.

124152	 	Filed April 21, 1998	 	
Process for transmitting, receiving and/or storing information

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00049-of-00352.parquet"}]]